LAUREN MORTON: Open Payments
NPI 1003269580 · BOYD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 8 companies in 2025. Trend: 2023 $900 · 2024 $405 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Antares Pharma, Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Novo Nordisk Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: XYOSTED, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, Ozempic, SPRAVATO, JARDIANCE, OTEZLA.
Industry payments across TX — which companies pay providers there.
